Quotes 5-day view Delayed Nyse
01/26/2023
01/27/2023
01/30/2023
01/31/2023
02/01/2023
Date
164.91(c)
164.16(c)
165.31(c)
168.96(c)
161.05(c)
Last
1 067 295
1 626 610
1 175 801
2 109 091
2 352 102
Volume
+0.89%
-0.45%
+0.70%
+2.21%
-4.68%
Change
Estimated financial data (e) USD GBP
Sales 2023
252 B
-
205 B
Net income 2023
2 118 M
-
1 720 M
Net Debt 2023
3 421 M
-
2 779 M
P/E ratio 2023
15,9x
Yield 2023
1,21%
Sales 2024
266 B
-
216 B
Net income 2024
2 364 M
-
1 920 M
Net Debt 2024
2 492 M
-
2 024 M
P/E ratio 2024
14,1x
Yield 2024
1,26%
Capitalization
32 570 M
32 570 M
26 458 M
EV / Sales 2023
0,14x
EV / Sales 2024
0,13x
Nbr of Employees
41 500
Free-Float
55,2%
AmerisourceBergen Corporation specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services,...
Ratings of AmerisourceBergen Corporation
All news about AMERISOURCEBERGEN CORPORATION
02/01 AMERISOURCEBERGEN CORP Management's Discussion and Analysis of Financial Condition and.. AQ
02/01 Transcript : AmerisourceBergen Corporation, Q1 2023 Earnings Call, Feb 01, 20.. CI
02/01 AmerisourceBergen's Fiscal Q1 Adjusted Earnings, Revenue Increase; Fiscal 2023 Guidance.. MT
02/01 Earnings Flash (ABC) AMERISOURCEBERGEN CORPORATION Posts Q1 Revenue $62.85B, vs. Street.. MT
02/01 Earnings Flash (ABC) AMERISOURCEBERGEN CORPORATION Reports Q1 Adjusted EPS $2.71, vs. S.. MT
02/01 Amerisourcebergen : Fiscal Q1 Earnings Snapshot AQ
02/01 North American Morning Briefing: Stock Futures -3- DJ
02/01 Amerisourcebergen Corp : Results of Operations and Financial Condition, Regulation FD Disc.. AQ
02/01 AmerisourceBergen Reports Fiscal 2023 First Quarter Results BU
02/01 AmerisourceBergen Corporation Declares a Quarterly Cash Dividend, Payable on February 2.. CI
02/01 AmerisourceBergen Corporation Reports Earnings Results for the First Quarter Ended Dece.. CI
02/01 An unknown buyer acquired Brazil specialty business from AmerisourceBergen Corporation. CI
01/31 Credit Suisse Raises AmerisourceBergen's Price Target to $197 From $182, Keeps Outperfo.. MT
01/31 UBS Adjusts AmerisourceBergen Price Target to $190 From $184, Maintains Buy Rating MT
01/31 Evercore ISI Reinstates AmerisourceBergen at Outperform With $185 Price Target MT
News in other languages on AMERISOURCEBERGEN CORPORATION
Analyst Recommendations on AMERISOURCEBERGEN CORPORATION
ETFs positioned on AMERISOURCEBERGEN CORPORATION ETFs and Trackers with Trackinsight
Chart AMERISOURCEBERGEN CORPORATION
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends AMERISOURCEBERGEN CORPORATION
Short Term Mid-Term Long Term Trends Bearish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
161,05 $
Average target price
181,58 $
Spread / Average Target
12,7%
Please enable JavaScript in your browser's settings to use dynamic charts.